Artificial intelligence and genomics
The lab develops and evaluates artificial intelligence models to study how genomic variation contributes to chronic disease.
Overview
The Artificial Intelligence-Driven Genomics for Chronic Diseases Laboratory led by Shant Ayanian, M.D.; Elena Myasoedova, M.D., Ph.D.; and Alexander J. Ryu, M.D., studies how differences in DNA contribute to chronic diseases. The team develops and tests artificial intelligence (AI) models that can find patterns in genetic data and connect those patterns with clinical information. The lab's work includes research on rheumatoid arthritis, inflammatory bowel disease, type 1 diabetes and selected cancer-related questions.
This work may help researchers better understand why diseases develop, identify groups of patients who share biological features and improve estimates of disease risk. The long-term goal is to support earlier and more individualized care. The lab's AI models are research tools that require further validation before they can be used to make clinical decisions.
The lab focuses on:
- Building and evaluating AI models that learn from DNA sequence data.
- Studying how genetic differences contribute to chronic immune-mediated diseases and selected cancers.
- Improving predictions about how genetic variants may affect health.
- Identifying patient groups with shared biological patterns.
- Combining genomic and clinical data to support future precision medicine research.
The lab brings together expertise in genomics, computational biology and clinical medicine. It collaborates with the Mayo Clinic Artificial Intelligence Program. Within the Department of Medicine, the Generative AI Network (GAIN) — a strategic research pillar — supports selected projects by providing shared technical expertise, data preparation workflows and research infrastructure.